Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
5.95
-0.04 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
6.10
+0.15 (2.52%)
Pre-market: Apr 29, 2026, 7:08 AM EDT
Plus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -22.39 | -12.98 | -13.32 | -20.28 | -13.4 | Upgrade
|
| Depreciation & Amortization | 0.45 | 0.87 | 0.63 | 0.71 | 0.42 | Upgrade
|
| Other Amortization | - | - | 0.19 | 0.39 | 0.55 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | - | 0 | - | 0.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.12 | - | 0.25 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.01 | -0.11 | - | - | - | Upgrade
|
| Stock-Based Compensation | 1.54 | 0.55 | 0.57 | 0.61 | 0.61 | Upgrade
|
| Other Operating Activities | 5.69 | -2.11 | 0.08 | -0 | -0.01 | Upgrade
|
| Change in Accounts Receivable | 0.25 | -0.57 | - | - | - | Upgrade
|
| Change in Accounts Payable | -5.62 | 4.7 | -3.68 | 6.45 | 1.73 | Upgrade
|
| Change in Unearned Revenue | - | -1 | 0.28 | 1.64 | - | Upgrade
|
| Change in Other Net Operating Assets | -0.67 | 0.09 | 2.28 | -2.5 | -0.5 | Upgrade
|
| Operating Cash Flow | -20.78 | -10.55 | -12.85 | -12.97 | -10.28 | Upgrade
|
| Capital Expenditures | -0.07 | -0.15 | -0.16 | -0.51 | -0.14 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.03 | - | - | - | 0.06 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.55 | - | -0.25 | - | Upgrade
|
| Investment in Securities | -0.82 | -3.42 | - | - | - | Upgrade
|
| Investing Cash Flow | -0.85 | -4.11 | -0.16 | -0.76 | -0.08 | Upgrade
|
| Short-Term Debt Issued | 0.75 | 3.29 | - | - | - | Upgrade
|
| Long-Term Debt Issued | 3.74 | - | - | - | - | Upgrade
|
| Total Debt Issued | 4.49 | 3.29 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | -3.29 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -3.7 | -4 | -1.61 | -1.61 | -0.28 | Upgrade
|
| Total Debt Repaid | -7 | -4 | -1.61 | -1.61 | -0.28 | Upgrade
|
| Net Debt Issued (Repaid) | -2.51 | -0.7 | -1.61 | -1.61 | -0.28 | Upgrade
|
| Issuance of Common Stock | 38.54 | 7.27 | 5.53 | 15.83 | 20.69 | Upgrade
|
| Repurchase of Common Stock | - | -0.37 | -0.13 | - | - | Upgrade
|
| Other Financing Activities | -5.72 | - | -0.35 | -0.77 | - | Upgrade
|
| Financing Cash Flow | 30.31 | 6.19 | 3.45 | 13.45 | 20.42 | Upgrade
|
| Net Cash Flow | 8.68 | -8.48 | -9.57 | -0.28 | 10.05 | Upgrade
|
| Free Cash Flow | -20.84 | -10.7 | -13.01 | -13.48 | -10.42 | Upgrade
|
| Free Cash Flow Margin | -399.81% | -183.72% | -264.83% | -6018.30% | - | Upgrade
|
| Free Cash Flow Per Share | -6.70 | -34.74 | -103.56 | -192.55 | -323.35 | Upgrade
|
| Cash Interest Paid | - | 0.03 | 0.22 | 0.33 | 0.39 | Upgrade
|
| Levered Free Cash Flow | -13.6 | -3.35 | -8.43 | -8.21 | -5.18 | Upgrade
|
| Unlevered Free Cash Flow | -13.26 | -3.24 | -8.37 | -8.15 | -5.14 | Upgrade
|
| Change in Working Capital | -6.04 | 3.22 | -1.12 | 5.6 | 1.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.